Aripiprazole in the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorder in Japan: A Randomized, Double-blind, Placebo-controlled Study

We evaluated the efficacy and safety of aripiprazole in the treatment of irritability in children and adolescents (6–17 years) with autism spectrum disorder (ASD) in a randomized, double-blind, placebo-controlled 8-week study in Japan. Patients received flexibly dosed aripiprazole (1–15 mg/day) or p...

Descripción completa

Detalles Bibliográficos
Autores principales: Ichikawa, Hironobu, Mikami, Katsunaka, Okada, Takashi, Yamashita, Yushiro, Ishizaki, Yuko, Tomoda, Akemi, Ono, Hiroaki, Usuki, Chiharu, Tadori, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617873/
https://www.ncbi.nlm.nih.gov/pubmed/28004215
http://dx.doi.org/10.1007/s10578-016-0704-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617873/
https://www.ncbi.nlm.nih.gov/pubmed/28004215
http://dx.doi.org/10.1007/s10578-016-0704-x

Ejemplares similares